These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1555101)

  • 1. Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arterial thrombolysis.
    Lonsdale RJ; Berridge DC; Earnshaw JJ; Harrison JD; Gregson RH; Wenham PW; Hopkinson BR; Makin GS
    Br J Surg; 1992 Mar; 79(3):272-5. PubMed ID: 1555101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a recently instituted programme of thrombolytic therapy in acute lower limb ischaemia.
    Dawson KJ; Reddy K; Platts AD; Hamilton G
    Br J Surg; 1991 Apr; 78(4):409-11. PubMed ID: 1903317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic agents for peripheral arterial occlusion.
    Robertson I; Kessel DO; Berridge DC
    Cochrane Database Syst Rev; 2010 Mar; (3):CD001099. PubMed ID: 20238313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic agents for peripheral arterial occlusion.
    Robertson I; Kessel DO; Berridge DC
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD001099. PubMed ID: 24357258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis.
    Berridge DC; Gregson RH; Hopkinson BR; Makin GS
    Br J Surg; 1991 Aug; 78(8):988-95. PubMed ID: 1913123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of agent for peripheral thrombolysis.
    Earnshaw JJ; Scott DJ; Horrocks M; Baird RN
    Br J Surg; 1993 Jan; 80(1):25-7. PubMed ID: 8428284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug variables in thrombolytic therapy.
    Meyerovitz MF
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):62S-65S. PubMed ID: 8770844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intra-arterial thrombolysis in peripheral bypass and arterial occlusions. Results and predictive factors for thrombolysis].
    Sandbaek G; Staxrud LE; Rosén L; Bay D; Stiris M; Gjølberg T
    Tidsskr Nor Laegeforen; 1996 Oct; 116(25):3000-4. PubMed ID: 8975423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial.
    Mahler F; Schneider E; Hess H;
    J Endovasc Ther; 2001 Dec; 8(6):638-47. PubMed ID: 11797982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage.
    Berridge DC; Makin GS; Hopkinson BR
    Br J Surg; 1989 Dec; 76(12):1230-3. PubMed ID: 2514002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential benefits from heating the high-dose rtPA boluses used in catheter-directed thrombolysis for acute/subacute lower limb ischemia.
    Tsetis DK; Katsamouris AN; Giannoukas AD; Hatzidakis AA; Kostas T; Chamalakis K; Ioannou C; Gourtsoyiannis NC
    J Endovasc Ther; 2003 Aug; 10(4):739-44. PubMed ID: 14533969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
    Enevoldsen MT; Rørdam P; Schroeder TV
    Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
    Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic treatment and balloon angioplasty in chronic occlusion of the aortic bifurcation.
    Pilger E; Decrinis M; Stark G; Koch G; Obernosterer A; Tischler R; Lafer M; Doder A
    Ann Intern Med; 1994 Jan; 120(1):40-4. PubMed ID: 8250455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic agents in critical care.
    Weiner B
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):355-66. PubMed ID: 8398041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early results and 1-year follow-up after intra-arterial thrombolysis.
    Browse DJ; Torrie EP; Galland RB
    Br J Surg; 1993 Feb; 80(2):194-7. PubMed ID: 8443648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?
    Collen D
    Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.